Stay updated on Dose-escalation SAR440234 Clinical Trial
Sign up to get notified when there's something new on the Dose-escalation SAR440234 Clinical Trial page.

Latest updates to the Dose-escalation SAR440234 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added, and notices for Revision: v3.4.1 and the government funding lapse notice were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a site-wide notice about government funding lapse and NIH Clinical Center operations, and the site revision label updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded Show glossary option; updated QC label to 'Last Update Submitted that Met QC Criteria' and revised page version to 'Revision: v3.4.0'; capitalization adjusted for 'No FEAR Act Data' vs 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4, reflecting a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new Locations section was added, including the Texas location (Houston, TX 77030). The page revision was updated to v3.3.3 and the separate Texas Locations entry and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check92 days agoChange DetectedMinor wording updates in the PubMed publications area clarifying automatic population from PubMed and updated revision labels (v3.3.2 added; v3.2.0 removed). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Dose-escalation SAR440234 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalation SAR440234 Clinical Trial page.